secwatch.observer — SEC 8-K summary
======================================

Issuer:     HEALTH DISCOVERY CORP (—)
CIK:        0001141788
Form:       8-K
Filed at:   2024-07-11T23:59:59+00:00
Accession:  0001683168-24-004754
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Health Discovery appoints Dr. Alan Hauser as CEO, replacing George McGovern
---------------------------------------------------------------------------

- Dr. Alan Hauser appointed CEO effective July 8, 2024, replacing former CEO George McGovern.
- Compensation includes $180K base salary and 1,000,000 restricted shares vesting July 8, 2025.
- Performance-based grants: 500K shares upon 6 months and 500K shares upon 12 months of employment.
- Hauser previously CEO of Arvetas Biosciences (2020-2024), focused on machine learning and precision medicine.
- Board cites his plan to evaluate IP, find commercial opportunities, and meet IRS/SEC requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1141788/000168316824004754/0001683168-24-004754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1141788/000168316824004754/health_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer